$44.18
+0.79 (+1.82%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+59.90%
YTD
+56.33%
Open$44.27
Previous Close$43.39
Day High$44.79
Day Low$43.11
52W High$55.67
52W Low$26.99
Volume—
Avg Volume1.48M
Market Cap7.36B
P/E Ratio111.32
EPS$0.38
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$31.02
Above
SMA 200
$29.87
Above
RSI (14)
32.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
25 analysts
Price Target
+186.1% upside
Current
$44.18
$44.18
Target
$126.40
$126.40
$90.34
$126.40 avg
$146.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.48B | 1.35B | 1.89B |
| Net Income | 242.94M | 198.95M | 267.01M |
| Profit Margin | 16.4% | 15.6% | 14.1% |
| EBITDA | 260.94M | 225.56M | 438.15M |
| Free Cash Flow | — | — | 233.31M |
| Rev Growth | +9.9% | +9.9% | +6.3% |
| Debt/Equity | — | — | 0.25 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |